Change from subcutaneous to intravenous abatacept and back in patients with rheumatoid arthritis as simulation of a vacation: a prospective phase IV, open-label trial (A-BREAK).
about
Change from subcutaneous to intravenous abatacept and back in patients with rheumatoid arthritis as simulation of a vacation: a prospective phase IV, open-label trial (A-BREAK).
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Change from subcutaneous to in ...... V, open-label trial (A-BREAK).
@en
type
label
Change from subcutaneous to in ...... V, open-label trial (A-BREAK).
@en
prefLabel
Change from subcutaneous to in ...... V, open-label trial (A-BREAK).
@en
P2093
P2860
P1476
Change from subcutaneous to in ...... IV, open-label trial (A-BREAK)
@en
P2093
Jean Dudler
Johannes von Kempis
Michael Gengenbacher
Ruediger B Mueller
Symi Richter
P2860
P2888
P356
10.1186/S13075-016-0985-2
P577
2016-04-14T00:00:00Z
P6179
1035637390